CIBC Innovation Banking Provides Growth Capital to KeyOps
TORONTO--(BUSINESS WIRE)-- CIBC Innovation Banking announced today that it has provided growth financing to KeyOps, a Toronto-based insights and engagement platform that connects physicians to life science companies. KeyOps will use the funds to invest in product development and expansion into the US market.
Founded in 2020, KeyOps helps improve health care by driving the digital transformation of knowledge and insights exchanged between pharmaceutical commercial teams and health care providers.
“Physician insights play an essential role in helping pharmaceutical companies make strategic decisions – but traditional engagement methods are time consuming and costly,” said Peter Doulas, CEO, KeyOps. “Our innovative, digital-first approach removes the friction from physician engagement providing pharmaceutical commercial teams with fast, accurate data from a diverse and trusted provider network. We are pleased to work with CIBC Innovation Banking as the team helps us accelerate our growth to the next stage and beyond.”
“We’re really excited to work with KeyOps as it solves a real pain point for both health care providers and pharmaceutical companies,” said Amy Olah, Managing Director in CIBC Innovation Banking’s Toronto office. “KeyOps is well positioned to fill the gap as more pharmaceutical commercial teams, physicians and companies shift to digital channels.”
About CIBC Innovation Banking
CIBC Innovation Banking delivers strategic advice, cash management and funding to innovation companies across North America, the UK, and select European countries at each stage of their business cycle, from start up to IPO and beyond. With offices in Atlanta, Austin, Boston, Chicago, Denver, Durham, London, Menlo Park, Montreal, New York, Reston, Seattle, Toronto and Vancouver, the team has extensive experience and a strong, collaborative approach that extends across CIBC’s commercial banking, private banking, wealth management and capital markets businesses.
About KeyOps
KeyOps is an insights and engagement platform that breaks down the communication barriers between life science companies and healthcare providers to enable better, real-time decision making for medical affairs, marketing and sales teams. Through a trusted and compliant digital platform, customers can build and manage on-demand relationships with a diverse, influential community of key opinion leaders and medical experts. For more information visit www.keyops.io, email at [email protected] or follow @keyopsinc on Twitter and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230627924248/en/
CAN: Katarina Milicevic, [email protected], 416-784-6108
Source: CIBC Innovation Banking
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tanger Recognized by Newsweek for Workplace Culture and by Nareit for Investor Communications Excellence
- Momentus Announces Pricing of a $25 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules with New and Existing Fundamental Institutional Investors
- OFA Group Receives Additional 180-Day Nasdaq Compliance Period; Nasdaq Confirms Company Remains Compliant with All Continued Listing Standards Other Than the Minimum Bid Price Requirement
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
CIBC, Twitter, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share